Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 3Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcopenia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Infections 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Wearable Electronic Devices × Clear all
NCT07325305 2026-04-13

PROTECT

Murdoch Childrens Research Institute

Phase NA Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Motor Activity, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Sarcopenia

NCT07030998 2025-11-17

WEARABLES

Murdoch Childrens Research Institute

Recruiting
150 enrolled

Infections, Neoplasms

NCT06590506 2024-09-19

HDM-PMP22

Centro Nacional de Investigaciones Oncologicas CARLOS III

Recruiting
300 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡